Tirona R G, Pang K S
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
Drug Metab Dispos. 1996 Aug;24(8):821-33.
The metabolic disposition of simultaneously delivered [14C]salicylamide (SAM) (100 microM) and a tracer concentration of its hydroxylated metabolite [3H]gentisamide (GAM) was studied with single-pass followed by recirculating rat liver perfusion (10 ml/min). The use of dual radiolabeling of precursor-product pairs in single-pass and recirculating perfusions allowed for characterization of the differential metabolism of preformed [3H]GAM and formed [14C]GAM, which arose in situ in the liver with [14C]SAM single-pass perfusion, and the behavior of circulating [14C]GAM, which behaved as a preformed species in recirculation. In both modes of perfusion, [14C]SAM was mainly sequentially metabolized to [14C]GAM-5-glucuronide, whereas [3H]GAM predominantly formed [3H]GAM-5-sulfate. The steady-state and time-averaged clearances of SAM were identical and approached the value of flow, yielding a high hepatic extraction ratio (E = 0.98). The apparent extraction ratio of formed GAM [E(mi) = 0.96] was greater than that of the preformed species [E(pmi) approximately 0.7]. Because the coupling of (SAM) oxidation and (GAM) glucuronidation was a plausible explanation for the observation, a novel physiological pharmacokinetic model was developed to interpret the data. In this model, the liver was divided into three zonal units, within which acinar distribution of enzymatic activities was considered, namely periportal sulfation, evenly distributed glucuronidation, and perivenous hydroxylation. Each zonal region was subdivided into extracellular, cytosolic, and endoplasmic reticulum compartments, with cytosolic (sulfotransferases) and microsomal (cytochromes P-450 and UDP-glucuronosyltransferase) enzymes being segregated intracellularly into the cytosolic compartment and endoplasmic reticulum compartment, respectively. The simulations provided a good prediction of the present experimental data as well as previously obtained data with increasing SAM concentration and retrograde flow and supported the contention that SAM oxidation and GAM glucuronidation are coupled.
采用单次通过后再循环的大鼠肝脏灌注法(10毫升/分钟),研究了同时给予的[14C]水杨酰胺(SAM)(100微摩尔)及其羟基化代谢物[3H]龙胆酰胺(GAM)示踪浓度的代谢分布。在单次通过和再循环灌注中使用前体-产物对的双重放射性标记,能够表征预先形成的[3H]GAM和原位形成的[14C]GAM的差异代谢,原位形成的[14C]GAM是在肝脏单次通过灌注[14C]SAM时产生的,以及循环中的[14C]GAM的行为,其在再循环中表现为预先形成的物质。在两种灌注模式下,[14C]SAM主要依次代谢为[14C]GAM-5-葡萄糖醛酸苷,而[3H]GAM主要形成[3H]GAM-5-硫酸盐。SAM的稳态和时间平均清除率相同,且接近血流量值,产生了较高的肝脏提取率(E = 0.98)。形成的GAM的表观提取率[E(mi) = 0.9
6]大于预先形成的物质的表观提取率[E(pmi)约为0.7]。由于(SAM)氧化和(GAM)葡萄糖醛酸化的偶联是对该观察结果的一个合理的解释,因此开发了一种新的生理药代动力学模型来解释这些数据。在该模型中,肝脏被分为三个区域单元,其中考虑了酶活性的腺泡分布,即门静脉周围硫酸化、均匀分布的葡萄糖醛酸化和肝静脉周围羟基化。每个区域进一步细分为细胞外、胞质和内质网区室,胞质(磺基转移酶)和微粒体(细胞色素P-450和UDP-葡萄糖醛酸基转移酶)酶分别在细胞内分隔到胞质区室和内质网区室。模拟结果很好地预测了当前的实验数据以及先前在增加SAM浓度和逆行血流情况下获得的数据,并支持了SAM氧化和GAM葡萄糖醛酸化是偶联的这一论点。